GB9806095D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9806095D0
GB9806095D0 GBGB9806095.7A GB9806095A GB9806095D0 GB 9806095 D0 GB9806095 D0 GB 9806095D0 GB 9806095 A GB9806095 A GB 9806095A GB 9806095 D0 GB9806095 D0 GB 9806095D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9806095.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9806095.7A priority Critical patent/GB9806095D0/en
Publication of GB9806095D0 publication Critical patent/GB9806095D0/en
Application status is Ceased legal-status Critical

Links

GBGB9806095.7A 1998-03-20 1998-03-20 Novel compounds Ceased GB9806095D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9806095.7A GB9806095D0 (en) 1998-03-20 1998-03-20 Novel compounds

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9806095.7A GB9806095D0 (en) 1998-03-20 1998-03-20 Novel compounds
PCT/EP1999/001894 WO1999049055A1 (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
CA 2323760 CA2323760A1 (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
EP19990916852 EP1064388A1 (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
AU35192/99A AU3519299A (en) 1998-03-20 1999-03-17 Human casb12 polypeptide, a serine protease
JP2000538015A JP2002507425A (en) 1998-03-20 1999-03-17 Human casb12 polypeptide is a serine protease

Publications (1)

Publication Number Publication Date
GB9806095D0 true GB9806095D0 (en) 1998-05-20

Family

ID=10829021

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9806095.7A Ceased GB9806095D0 (en) 1998-03-20 1998-03-20 Novel compounds

Country Status (6)

Country Link
EP (1) EP1064388A1 (en)
JP (1) JP2002507425A (en)
AU (1) AU3519299A (en)
CA (1) CA2323760A1 (en)
GB (1) GB9806095D0 (en)
WO (1) WO1999049055A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921658B1 (en) 1998-11-20 2005-07-26 Fuso Pharmacutical Industries, Ltd. Serine protease BSSP6
HU0200366A2 (en) * 1999-03-11 2002-06-29 Smithkline Beecham Biolog Novel compounds
US20020102641A1 (en) * 2000-03-24 2002-08-01 Susan Schia Vi Oncogenic osteomalacia-related gene 1
WO2002012461A2 (en) * 2000-08-07 2002-02-14 Bayer Aktiengesellschaft Regulation of human membrane-type serine protease
AU1394902A (en) * 2000-09-25 2002-04-02 Bayer Ag Regulation of human serine protease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5840871A (en) * 1997-01-29 1998-11-24 Incyte Pharmaceuticals, Inc. Prostate-associated kallikrein
CA2311572A1 (en) * 1997-12-17 1999-06-24 Genset S.A. Extended cdnas for secreted proteins

Also Published As

Publication number Publication date
JP2002507425A (en) 2002-03-12
CA2323760A1 (en) 1999-09-30
EP1064388A1 (en) 2001-01-03
WO1999049055A1 (en) 1999-09-30
AU3519299A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
GB9818731D0 (en) Compounds
PL353156A1 (en) Compounds
GB9804734D0 (en) Compounds
GB9819847D0 (en) Novel compounds
GB9803411D0 (en) Novel compounds
GB9801392D0 (en) Novel compounds
GB9920332D0 (en) Novel compound
GB9804175D0 (en) Compounds
GB9808327D0 (en) Antidiotypic compounds
GB9819681D0 (en) Novel compounds
GB9815163D0 (en) Compounds
GB9810193D0 (en) Novel compounds
GB9816984D0 (en) Novel compounds
GB9922519D0 (en) Compounds
GB9810276D0 (en) Novel compounds
GB9808866D0 (en) Novel compounds
GB9826941D0 (en) Compounds
GB9922521D0 (en) Compounds
GB9919873D0 (en) Compounds
GB9808734D0 (en) Novel compounds
IL139955D0 (en) Lantithrombotic compounds
GB9825554D0 (en) Novel Compounds
GB9818881D0 (en) Compounds
GB9828419D0 (en) Novel compounds
GB9822241D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)